Elicit: AI for Scientific ResearchSkip to main contentLoading Preparing your review.Loading...LoadingPreparing your review.
Data availability The dataset(s) supporting the conclusions of this article were obtained from the TriNetX platform ( Access to TriNetX data is available under license to participating institutions
Albiglutide was associated with fewer hypoglycemic events and moderate weight loss, but Albiglutide based on fusion protein technology produced more antibodies due to its functional protein domain
It is accompanied by cardiovascular benefits, including significant blood pressure reduction, lipid improvements, and dramatic weight loss, that almost certainly produce a net positive cardiovascular effect
New Approvals Already Reshaping the Market Two significant regulatory decisions in early 2026 have shifted the competitive dynamics of the GLP-1 drug pipeline before the year reached its midpoint
SCARA5, scavenger receptor class A member 5